Ondansetron 4 mg/1 TABLET, ORALLY DISINTEGRATING
Glenmark Pharmaceuticals Inc., USA
FDA Drug Information
Indications & Usage
1 INDICATIONS AND USAGE Ondansetron is indicated for the prevention of nausea and vomiting associated with: • highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m 2 • initial and repeat courses of moderately emetogenic cancer chemotherapy • radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen Ondansetron is also indicated for the prevention of postoperative nausea and/o…
Source: FDA. For professional use only. Not a substitute for prescribing information.
Other Ondansetron NDC Codes
Wholesale and compliance resources
Order NDC 68462-0157-13 at Wholesale
Create a free Premier Pharma account to unlock live wholesale pricing and place orders with same-day fulfillment and full DSCSA T2 documentation (TI + TS).